Space is limited at in-person event and early registration is recommended.
Pending Accreditation for 1 CEU. CEUs will be available for in-person or live virtual webinar attendance only!
When cancer therapy and cardiovascular health collide, timely recognition and management are critical.
This July, Margaret Sidsworth will lead a hybrid session at the University of British Columbia, exploring key cardio‑oncology challenges including cardiovascular risk, treatment‑related cardiotoxicity, and myocarditis.
In person attendees enjoy free dinner and networking!
By the end of this session, participants will be able to:
-
Identify cardiovascular risk in patients with cancer and apply prevention strategies
-
Recognize and manage fluoropyrimidine-associated cardiotoxicity
-
Optimize management of immune-checkpoint-inhibitor myocarditis
About Margaret Sidsworth, B.Sc Pharm, ACPR
As a graduate of University of British Columbia, Margaret has spent the past 16 years practicing in the Heart Function and Cardio-Oncology Clinic at Vancouver General Hospital. Alongside her clinical work, she am actively engaged in research, training, and knowledge translation, with a focus on advancing cardiovascular care in patients with cancer.